Literature DB >> 19029994

A patient with stress-related onset and exacerbations of Graves disease.

Roberto Vita1, Daniela Lapa, Giuseppe Vita, Francesco Trimarchi, Salvatore Benvenga.   

Abstract

BACKGROUND: An 18-year-old, nonsmoking woman presented to her general practitioner with a 1-week history of weakness, fatigue, palpitations, nervousness, tremors, insomnia, heat intolerance, and sudden enlargement of a thyroid goiter that had been detected 2 years earlier. The patient's symptoms had started shortly after she experienced emotional stress. Diagnostic work-up disclosed an avid radioactive iodine uptake by the goiter. On ultrasound examination, the thyroid gland was enlarged with a diffusely hypoechogenic structure and intense vascularization. INVESTIGATIONS: Thyroid scintigraphy with (131)I; ultrasonography of the thyroid gland; and measurements of serum free T(3), free T(4), TSH levels and thyroid autoantibodies, including autoantibodies against thyroglobulin (TgAb), thyroperoxidase (TPOAb) and TSH receptor (TRAb). DIAGNOSIS: Graves disease, with stress-related onset and subsequent stress-related exacerbations. MANAGEMENT: The patient was treated with methimazole to normalize levels of thyroid hormone and thyroid autoantibodies, and with bromazepam to help her cope with stress. The daily dose of methimazole was kept low during pregnancy. Over the 4 year period when the patient was taking methimazole, exacerbations of hyperthyroidism occurred twice: during her first pregnancy and 9 months after her first delivery. On all three occasions, symptoms were preceded by stressful life events. Further exacerbations were avoided by starting bromazepam treatment soon after the patient experienced stressful events.

Entities:  

Mesh:

Year:  2008        PMID: 19029994     DOI: 10.1038/ncpendmet1006

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  21 in total

1.  The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.

Authors:  Atsushi Fukao; Junta Takamatsu; Yasuhiro Murakami; Sadaki Sakane; Akira Miyauchi; Kanji Kuma; Shunichiro Hayashi; Toshiaki Hanafusa
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

Review 2.  Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.

Authors:  L P Longo; B Johnson
Journal:  Am Fam Physician       Date:  2000-04-01       Impact factor: 3.292

3.  Stress and auto-immune endocrine diseases.

Authors:  J Leclère; G Weryha
Journal:  Horm Res       Date:  1989

Review 4.  Lymphocyte hormone receptors.

Authors:  M Plaut
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

5.  Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues.

Authors:  Estelle Bribes; Dominique Carrière; Catherine Goubet; Sylvaine Galiègue; Pierre Casellas; Joêlle Simony-Lafontaine
Journal:  J Histochem Cytochem       Date:  2004-01       Impact factor: 2.479

Review 6.  The environment and autoimmune thyroid diseases.

Authors:  Mark F Prummel; Thea Strieder; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

7.  Benzodiazepines inhibit temperature-dependent L-[125I]triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines.

Authors:  L Kragie; D Doyle
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

8.  Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.

Authors:  Marcos Abalovich; Nobuyuki Amino; Linda A Barbour; Rhoda H Cobin; Leslie J De Groot; Daniel Glinoer; Susan J Mandel; Alex Stagnaro-Green
Journal:  J Clin Endocrinol Metab       Date:  2007-08       Impact factor: 5.958

9.  A population-based study of Graves' disease in Danish twins.

Authors:  T H Brix; K Christensen; N V Holm; B Harvald; L Hegedüs
Journal:  Clin Endocrinol (Oxf)       Date:  1998-04       Impact factor: 3.478

10.  Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.

Authors:  L R Dolovich; A Addis; J M Vaillancourt; J D Power; G Koren; T R Einarson
Journal:  BMJ       Date:  1998-09-26
View more
  13 in total

1.  Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 2.  Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers.

Authors:  Christoph Langenstein; Diana Schork; Klaus Badenhoop; Eva Herrmann
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

3.  Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.

Authors:  Nicholas T Vozoris; Richard S Leung
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 4.  Molecular mimicry and autoimmune thyroid disease.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

5.  Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder.

Authors:  Wanqiu Yang; Miao Qu; Rui Jiang; XiaoE Lang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-18       Impact factor: 5.760

6.  The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.

Authors:  Atsushi Fukao; Junta Takamatsu; Sumihisa Kubota; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Biopsychosoc Med       Date:  2011-08-09

Review 7.  Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association.

Authors:  Mathilde Versini
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-21       Impact factor: 5.555

Review 8.  Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance.

Authors:  Ines Bucci; Cesidio Giuliani; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-30       Impact factor: 5.555

Review 9.  Management of Endocrinopathies in Pregnancy: A Review of Current Evidence.

Authors:  Daniela Calina; Anca Oana Docea; Kirill Sergeyevich Golokhvast; Stavros Sifakis; Aristides Tsatsakis; Antonis Makrigiannakis
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

Review 10.  Chemokines in hyperthyroidism.

Authors:  Silvia Martina Ferrari; Ilaria Ruffilli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Armando Patrizio; Valeria Mazzi; Alessandro Antonelli; Poupak Fallahi
Journal:  J Clin Transl Endocrinol       Date:  2019-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.